About Ginolis
Ginolis is a company based in Oulunsalo (Finland) founded in 2010 was acquired by CELLINK in February 2021. Ginolis has raised $2.41 million across 4 funding rounds from investors including CELLINK, European Union and Verso Capital. Ginolis offers products and services including PMBi Dispensing Pump, Cecilia-L Dispenser, Ginolis LFDA-1, and Kaiku Data Collection Service. Ginolis operates in a competitive market with competitors including Opentrons, LabCyte, Tecan, Transcriptic and Andrew Alliance, among others.
- Headquarter Oulunsalo, Finland
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ginolis Oy
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ginolis
Ginolis offers a comprehensive portfolio of products and services, including PMBi Dispensing Pump, Cecilia-L Dispenser, Ginolis LFDA-1, and Kaiku Data Collection Service.
High precision pump for non-contact liquid handling in manufacturing.
Automated dispenser for microfluidic device production processes.
Module for manufacturing lateral flow diagnostic tests efficiently.
Software for insights into manufacturing processes and optimization.
People of Ginolis
Unlock access to complete
Funding Insights of Ginolis
Ginolis has successfully raised a total of $2.41M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $571.61 thousand completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ginolis
Ginolis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include CELLINK, European Union and Verso Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are targeted by this private equity firm.
|
Locked | Locked | Locked | |
|
Springvest is recognized as a leading growth investment service in Finland.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Ginolis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ginolis
Investment portfolio details for Ginolis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ginolis
Detailed financials for Ginolis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ginolis Comparisons
Peer comparison for Ginolis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ginolis
Ginolis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, LabCyte, Tecan, Transcriptic and Andrew Alliance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pipetting robots for laboratory automation are developed.
|
|
| Locked | Locked | Locked |
Acoustic liquid handling is developed for life science research.
|
|
| Locked | Locked | Locked |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based robotic bio-lab services are delivered remotely for experiment execution.
|
|
| Locked | Locked | Locked |
Provider of automated liquid handling tools and software for scientific labs
|
|
| Locked | Locked | Locked |
Scalable robotic platforms are provided for microbiology lab automation.
|
Detailed competitors of Ginolis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ginolis
Complete news archive for Ginolis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ginolis
Ginolis was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Ginolis is headquartered in Oulunsalo, Finland. It is registered at Oulunsalo, Northern Ostrobothnia, Finland.
Ginolis is a funded company, having raised a total of $2.41M across 4 funding rounds to date.
Ginolis was established in 2010 in Oulunsalo, Finland, focusing on the life sciences and healthcare sectors. Liquid handling robots are produced for laboratory applications, enabling tasks including micro assembly, lateral flow device assembly, quality control, and automation design. The Delilah platform serves as a versatile system for diagnostic test manufacturing and lab processes, functioning independently or within integrated robotic setups. Operations center on enhancing efficiency in research and production environments.
Ginolis's top competitors include Opentrons, Tecan and Andrew Alliance.
Ginolis offers PMBi Dispensing Pump, Cecilia-L Dispenser, Ginolis LFDA-1, and Kaiku Data Collection Service.
Ginolis has 4 investors. Key investors include CELLINK, European Union, Verso Capital, and Springvest.